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SUMMARY 
Objective: Surgery is a stressor that can be categorized by duration and severity, and induces 
a systemic stress response that includes increased adrenal cortisol production. However, the 
precise impact of surgical stress on the cortisol response remains to be defined. 
Design: We performed a systematic review and meta-analysis to assess the cortisol stress 
response induced by surgery and to stratify this response according to different parameters. 
Methods: We conducted a comprehensive search in several databases from 1990 to 2016. 
Pairs of reviewers independently selected studies, extracted data and evaluated the risk of 
bias. Cortisol concentrations were standardized, pooled in meta-analysis and plotted over 
time. 
Results: We included 71 studies reporting peri-operative serum cortisol measurements in 
2,953 patients. The cortisol response differed substantially between moderately/highly 
invasive and minimally invasive surgical procedures. Minimally invasive procedures did not 
show a peri-operative cortisol peak, whereas more invasive surgeries caused a cortisol surge 
that was more pronounced in older subjects, women and patients undergoing open surgery 
and general anaesthesia. The duration of the procedure and the use of etomidate for induction 
of anaesthesia did not affect the cortisol response. 
Conclusions: The peri-operative cortisol stress response is dynamic and influenced by 
patient-specific, surgical and anaesthetic features. However, the available evidence is derived 
from highly heterogeneous studies, with only two of 71 studies measuring cortisol by mass 
spectrometry, which currently prevents a precise and reproducible definition of this response. 
 
Key words: Cortisol; Surgery; Stress; Pituitary-Adrenal System; Adrenal Insufficiency; 
Hydrocortisone; Adrenal cortex.  
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INTRODUCTION 
The controlled trauma of a surgical insult activates adaptive changes in the neuro-
hormonal system and the inflammation response.1 The primary mechanism responsible for 
cortisol hypersecretion in response to stress is executed by the afferent nerve signals derived 
from the surgical site, which in turn stimulate the hypothalamus to release corticotropin-
releasing hormone and arginine vasopressin.2 These two peptides then stimulate secretion of 
adrenocorticotropic hormone from the anterior pituitary, which stimulates cortisol secretion 
by the adrenal cortex. Surgery can be considered a standardized model for assessing the 
cortisol response to stress and relevant modifying factors.  
Understanding the expected magnitude of cortisol production during surgical stress is 
very relevant, especially for patients with adrenal insufficiency who require a dose increase in 
exogenous cortisol replacement during stress. Primary and secondary adrenal insufficiency 
affects up to 424/1,000,000 people and comes with the need for lifelong glucocorticoid 
replacement.3 Furthermore, according to a recent meta-analysis,4 2.4-21.5% of patients 
receiving chronic treatment with supraphysiological exogenous steroids, e.g. for chronic 
obstructive pulmonary disease, develop tertiary adrenal insufficiency after glucocorticoid 
discontinuation. In all these patients, surgical stress required an increase in glucocorticoid 
replacement dose to avoid a life-threatening adrenal crisis. 
Recommendations regarding the dose, administration route, timing, tapering and 
duration of glucocorticoid therapy vary substantially.5 Moreover, the recommended doses of 
perioperative steroid dosing is based on the long-held notion that the activation of the 
hypothalamic-pituitary-adrenal (HPA) axis, including the adrenal cortisol output in response 
to surgery, is directly proportionate to the severity of the surgical stress.6-8 However, most of 
the data underpinning this assumption derive from works published before 1990 and are 
based on limited case series. Surgical and anaesthetic techniques, as well as the rigour of 
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cortisol assays have changed significantly since then, in particular following the now more 
widespread introduction of the current diagnostic reference standard mass spectrometry.  
Therefore, our objective was to perform a systematic review and meta-analysis of 
published studies investigating the cortisol response to surgery in order to estimate the 
expected range of perioperative cortisol concentrations and to identify factors that potentially 
affect this response. 
 
METHODS AND EVIDENCE ACQUISITION 
This systematic review and meta-analysis was performed based on an a priori 
protocol. The methods and results of the review are reported according to the PRISMA 
statement (preferred reporting items for systematic reviews and meta-analyses).9 
Inclusion and exclusion criteria 
We included original studies published after 1990 that enrolled adult humans 
undergoing any type of surgical procedure (under local or general anaesthesia), with a sample 
size of at least 5, and which reported at least one measurement of serum cortisol by any 
method during surgery and within 10 days from surgery. Studies published before 1990 were 
not considered representative of the recent advances in surgical and anaesthetic techniques, as 
well as of current methods for cortisol estimation used in clinical practice. Studies reporting 
cortisol measurements only after the administration of exogenous glucocorticoids or 
corticotropic agents (i.e. tetracosactide) were excluded. Surgical procedures involving the 
brain were also excluded to remove the potential confounding factor of surgically-induced 
central adrenal insufficiency.10  
Data sources and search strategy 
A comprehensive search of several databases was conducted for records published 
between 1990 and May 26th, 2016. The databases included Medline In-Process & Other 
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Non-Indexed Citations, MEDLINE, EMBASE, Cochrane Central Register of Controlled 
Trials, and Cochrane Database of Systematic Reviews. The search strategy was designed and 
conducted by an experienced librarian (LJP) with input from the corresponding author (IB). 
Controlled vocabulary supplemented with keywords was used to search for articles of 
interest. The full search strategy is available in Supplementary Table 1.  
Study selection 
Initial screening of the identified studies was performed by four independent 
reviewers (AP, KA, HKA and IB). Titles and abstracts of the identified studies were screened 
in duplicate, taking into consideration the predefined inclusion criteria. Many of the identified 
studies retrieved by our search were not relevant or not original and were excluded at this 
phase. The full-text screening was then performed in duplicate to assess eligibility for final 
inclusion and discrepancies were resolved through discussion and consensus. The reference 
lists of the original studies and narrative eviews were searched for any additional relevant 
studies that were not identified by our literature search. The list and characteristics of the 
included studies is reported in Table 1. 
Data extraction and variable and outcome definitions 
Data extraction of the eligible studies was carried out independently and in duplicate 
(AP, KA, HKA and IB) using the DistillerSR online platform, Evidence Partners.11 Any 
disagreements or discrepancies in extracted data were resolved by consensus.  
The data initially extracted included the last name of the first author and year of 
publication, the country where the study was conducted, demographics of participants, patient 
inclusion and exclusion criteria, and study design. The reviewers then extracted the cortisol 
measurements from all the eligible studies, dividing them by the time since the baseline 
assessment (prior to surgery). When exact figures were not reported in the text, cortisol 
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measurements and descriptive statistics were extracted from graphs. All cortisol 
measurements were converted to SI units (nmol/L).  
Finally, we considered various parameters potentially affecting cortisol concentrations 
during and after surgery (age, gender, grade and duration of surgical procedure, type of 
anaesthesia use and type of serum total cortisol assay) and extracted these data from the 
studies for which this information was available with the plan to perform subgroup analyses.  
The surgical procedures were classified according to the modified Johns Hopkins 
surgical criteria, which define three grades of invasiveness (Supplementary Table 2): 
minimally invasive (grade I), moderately invasive (grade II), and highly invasive (grade 
III).12 Supplementary Table 3 reports the parameters that have been extracted and used to 
generate specific subsets of patients, as well as the number of cohorts and sample sizes used 
for meta-analysis of the cortisol measurements. The latter are reported according to the time 
of measurement, ranging from baseline to the 7th post-operative day (POD-7). 
Methodological quality and risk of bias assessment 
Critical appraisal of the included studies was assessed independently and in duplicate 
(AP, KA, HKA and IB). Therefore, we derived the following parameter from an existing 
guide on appraising uncontrolled studies 13: (i) inclusion criteria; (ii) exclusion criteria; (iii) 
cortisol assay; (iv) timing of cortisol measurements; (v) reporting of cortisol measurements; 
(vi) time points of cortisol measurements. Any disagreements or differences in the quality 
assessments were resolved by consensus. 
Statistical analysis 
We conducted a meta-analysis using the random-effects model to pool estimates from 
the included studies. A random-effects model was used, rather than a fixed-effects model, in 
order to account for heterogeneity between-study and within-study variability. We used the I2 
statistic to estimate the percentage of total between-study variation due to heterogeneity 
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rather than chance (ranging from 0 to 100%). I2 values of 25, 50 and 75% are considered to 
represent low, moderate and high heterogeneity, respectively. Statistical analyses were 
conducted using OpenMeta[Analyst].14-16 The outcome of interest was total serum cortisol 
concentration, a continuous outcome that was extracted from the studies as means and 
standard deviations when possible. If the standard deviations were not reported, we converted 
the standard errors or interquartile ranges to standard deviations. Medians were used in place 
of means when the means were not reported and the sample size was 25 or more. The area 
under the curve (AUC) was calculated using the trapezoidal rule. AUCs have been then 
divided by 24-h intervals and compared either to the pre-operative cortisol measurements or 
to a standard AUC 0-24-h fo  cortisol derived from the literature (data from cortisol profiling 
of 33 healthy adults sampled over 24 hours every 20 minutes).17,18 Most studies in this 
systematic review reported multiple cortisol measurements during the day of surgery (i.e. the 
first 24 hours after the baseline assessment). From the 1st post-operative day (POD-1) 
onwards only single measurements every 24 hours were reported. To compare post-surgical 
cortisol secretion to the day of surgery cortisol secretion, we calculated the cortisol AUCs of 
each 24-h-interval. 
 
RESULTS 
Characteristics of included studies 
The search yielded 7,634 references for the abstract screening of which 71 studies 19-89 
were included in the analysis (Table 1). The PRISMA flow diagram (Figure 1) details the 
number of records identified, included and excluded, and the reasons for exclusions. Eligible 
studies included are predominantly prospective (n=34 interventional and n=36 observational), 
while one study is of retrospective-prospective nature. Most of the studies are from European 
(n=39) and Asian-Pacific centres (n=22) while ten studies originated from American centres.  
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A total of 2,953 patients (mean age 54 years, 50.2% women) undergoing surgery 
(n=223 grade I minimally invasive surgery, n=1,568 grade II moderately invasive surgery, 
and n=1,162 grade III highly invasive surgery, Table 1) were included. The mean duration of 
surgery was 154 min (range 24-495) min as reported by 42/71 studies. 
Peri-operative cortisol measurements were extracted from the studies and included 
baseline assessment (prior to surgery) up to 7th post-operative day (POD-7). As described in 
Supplementary Table 3, the number of observations up to POD-2 was high (>9,000 single 
cortisol measurements). However, the number of patient cohorts with available cortisol 
measurement between POD-3 and POD-7 available for analysis dropped considerably (<600 
single cortisol measurements).  
Most of the studies were judged to be of good quality (Supplementary Table 4); low 
quality scores were mainly due to absent or inadequate description of inclusion and exclusion 
criteria (especially the latter). Overall, the included studies clearly reported the methodology 
and the timing of cortisol measurements. For those studies reporting more than one patient 
cohort, the reviewers were almost always able to discriminate the cortisol measurements 
among the different cohorts and perform sub-group analyses (Supplementary Tables 3 and 
5). 
Grade of surgery and peri- and post-operative cortisol concentrations  
Four studies (n=194 patients) reported data for grade I (minimally invasive) 
procedures, while the cortisol response during grade II and grade III surgeries has been 
investigated in 41 (n=1,494 patients) and 22 studies (n=1,095 patients), respectively. Four 
studies (n=170 patients) reported cortisol measurements from mixed cohorts, ranging across 
the three grades of surgery (Table 1 and Supplementary Table 3). Whilst grade II surgical 
procedures were heterogeneous in terms of the type of surgery and surgical techniques, most 
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of the studies on grade III procedures (16 out of 24) focused on cardiac surgery, mainly 
coronary artery bypass grafting (CABG), Table 1. 
Cortisol measurements from patients undergoing grade I surgery have been performed 
only over a period of up to 24 hours after surgery, while patients undergoing grade II and III 
surgeries have been evaluated for cortisol up to POD-7 (Table 2 and Supplementary Table 
3). In order to increase the number of observations, we have also merged data from grade II 
and III procedures and these results are reported in Table 2 and Figure 2B+F. 
In our systematic review, we found that grade of surgery significantly affected 
cortisol secretion. Patients undergoing grade I surgery did not show an intraoperative cortisol 
peak, and even demonstrated lower intraoperative cortisol measurements when compared to 
baseline; post-surgical cortisol concentrations were again similar to baseline when measured 
within 6 hours after the procedure (Figure 2C). Nevertheless, when compared to published 
data on healthy, unstressed adults,17,18 the mean cortisol output over the first 24 hours after 
grade I surgical procedure is approximately doubled. On the other hand, patients undergoing 
grade II and III surgery had 1.9-fold and 1.7-fold, respectively, higher cortisol output within 
the first 24-h period than patients with grade I surgery, and 4-fold and 3.5-fold higher cortisol 
output than healthy, unstressed individuals. Total serum cortisol peaked around the time of 
extubation (grade II procedures) and between 6 and 18h after the end of surgery (grade III 
procedures) (Figure 2A). Moreover, in both grade II and III surgeries, mean cortisol values 
remained elevated in comparison to the baseline measurements up to POD-7 (Figure 2D-F).  
Demographics and peri- and post-operative cortisol concentrations 
After stratifying the combined cohorts of grade II and III procedures according to age 
(cut-off 60 years), we observed that older patients demonstrated higher cortisol 
concentrations (Figure 3A). In comparison to cohorts with female predominance (79% on 
average), in studies with >50% male patients (78% on average) the cortisol output was lower 
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the first 24-h from surgery but higher on POD1 (Figure 3B). The AUCs for total cortisol 
measurements, stratified by age and gender, are reported in Supplementary Table 5. 
Duration of surgery and peri- and post-operative cortisol concentrations 
When dividing the cohorts according not only to the grade but also the mean duration 
of surgery (≤180 or >180 min, 884 patients vs. 875 patients, respectively), we found that 
duration of surgery did not substantially affect the cortisol response within 48 hours of 
surgery (Figure 3C+D). The AUCs for total cortisol measurements are reported in 
Supplementary Table 5. 
Surgical and anaesthetic techniques and peri- and post-operative cortisol concentrations 
A laparoscopic surgical approach (n=446 patients) was associated with a slightly 
lower cortisol response during and after surgery as compared to open surgery (n=654 
patients) (Figure 4A). Conversely, studies with >50% of patients treated preoperatively with 
the anaesthetic agent etomidate, a known inhibitor of CYP11B1 and hence cortisol 
synthesis,90,91 have not demonstrated significant differences in cortisol response (n=502 
patients vs. n=1,444 patients who did not receive etomidate) (Figure 4B). Three studies 
(n=134 patients) compared general anaesthesia to regional (spinal or epidural) anaesthesia; 
the latter group had a 17% lower AUC for total cortisol over the first 24 hours after the 
initiation of surgery (Figure 4C). The AUCs for total cortisol measurements, stratified by 
surgical and anaesthetic techniques, are reported in Supplementary Table 5. 
Effect of cortisol assay on peri- and post-operative cortisol concentrations 
As expected, the types of cortisol assays used in the studies varied, with 63 studies 
using immunoassays, two liquid chromatography-tandem mass spectrometry (LC-MS/MS), 
two spectrophotometry and one double isotope dilution (Table 1). Three studies did not 
report the assay used. Perioperative total cortisol concentrations measured by immunoassay 
were higher when compared to cortisol measurements by LC-MS/MS – Figure 4D. While we 
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found no significant differences based on the type of immunoassay used, total cortisol 
measurements with ELISA demonstrated the highest measurements up to POD-1. The AUCs 
for total cortisol measurements stratified by the assay are reported in Supplementary Table 
5. None of the included studies utilised LC-MS/MS to measure total cortisol between 
baseline (prior to the initiation of surgery) and POD-1; thus, the AUCs for the first 24-h could 
not be compared between immunoassays and LC-MS/MS. 
 
DISCUSSION 
Surgery causes a controlled systemic stress response that encompasses a wide range 
of endocrine, immune and cardiovascular effects.2 In this systematic review and meta-
analysis, we focused on the surgery-induced HPA axis activation with an objective to 
estimate cortisol output and their dependence on several defined parameters.  
We found that the cortisol response to surgical stress varies significantly in patients 
undergoing minimally invasive surgeries (grade I) in comparison to patients undergoing 
moderate and highly invasive surgeries (grade II and III). On the day of surgery, the cortisol 
output increases by 2-fold (grade I), 4-fold (grade II) and 3.5-fold (grade III) in comparison 
to a reference population of healthy individuals. 
Interestingly, we found that grade I procedures do not cause a peri-operative cortisol 
peak. Moreover, cortisol actually decreases in comparison to pre-surgical measurements, 
possibly explained by the fact that the (minor) stress stimulus is counteracted by other 
factors, such as anaesthesia and sedation. It is important to keep in mind that only 6 studies 
on 223 patients reported on cortisol measurements after minor surgeries, and strong 
conclusions are not possible. 
We found that the cortisol response does not differ substantially between moderately 
(grade II) and highly invasive (grade III) surgeries with serum cortisol peaking between the 
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time of extubation and 18h after surgery, and increased cortisol concentrations noted up to 1 
week after surgery. Studies included in the current systematic review were highly 
heterogeneous in terms of patient selection, surgical and anaesthetic techniques, peri-
operative care and methodological aspects – all these factors can affect the cortisol stress 
response to surgery (Supplementary Table 6).92-98 Recently, Khoo B., et al. 99 reported on 
the peri-operative cortisol response after stratifying surgical procedures according to the 
POSSUM scoring system 100 and observed a positive correlation of cortisol peak to the 
invasiveness of the surgical procedure.99 We believe that several elements can account for the 
differences compared to the results of our systematic review, including (i) a different 
classification system, (ii) difference in demographics, and (iii) the difference in procedures. 
Studies published before 1990 suggested that serum cortisol during major surgery 
rises rapidly but usually returns to baseline values within 24-48-h.7 Our data, on the contrary, 
show that mean cortisol can remain higher than baseline measurements for a longer duration, 
up to POD-7. For example, the study by Naito Y., et al. (included in this systematic-review 
and meta-analysis) measured cortisol at 1-h intervals in patients undergoing elective upper 
abdominal surgery up to POD-7 and showed that cortisol levels remained elevated for more 
than 3 days after surgery, with a loss of the circadian rhythm.23 However, it is important to 
highlight that our results regarding the cortisol response after POD-3 derive only from a 
limited number of studies with small sample sizes.  
 Our data show that older subjects tend to have a higher peri-operative cortisol 
response. This can partly be explained by the fact that these patients (i) can have multiple 
comorbidities and a poorer pre-operative performance status, (ii) have a higher risk of post-
operative complications and (iii) often require non-elective surgery. In addition, some age-
related physiological changes of the HPA axis should be taken into account. In fact, older, 
non-stressed patients show a flattened circadian cortisol rhythm, and are likely to have higher 
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cortisol values in comparison to younger controls.101 A further confounding factor is that 
cortisol measurements might underestimate the actual cortisol production in older patients. In 
fact, some authors observed a reduction of cortisol-binding globulin (CBG) with age, 
especially in males,102 although this has not been confirmed by others.103 Further studies are 
needed to investigate which mechanisms actually affect the age-related cortisol response 
induced by surgery. In fact, the number of older patients undergoing surgical procedures is 
increasing over recent decades, and higher post-operative cortisol values in the older patient 
population with an increased risk of complications (e.g. cognitive dysfunction).65,83 This may 
also have a bearing when considering glucocorticoid stress supplementation in older 
hypoadrenal patients undergoing surgery. 
Laparoscopic surgery triggers a less robust acute phase and immune response in 
comparison to open procedures, and is also associated with a reduction of post-operative pain 
and hospital stay.104-107 Our data on the cortisol response from abdominal and pelvic 
laparoscopic procedures are in line with these observations, although large-scale, prospective 
studies are lacking. Similarly, our results regarding the effects of etomidate on the post-
operative cortisol response are based on a quite disproportionate comparison of only 8 studies 
in comparison to 38 studies without etomidate. Moreover, the regimens and doses of 
etomidate used throughout the studies varied considerably, and inhibition of the major 
cortisol biosynthesis enzyme CYP11B1 by cortisol will invariably result in accumulation of 
11-deoxycortisol, which can cross-react with cortisol immunoassays, leading to ‘falsely’ 
elevated cortisol values.108 These factors may explain why we did not observe the well-
known inhibitory effect of etomidate on cortisol production.109 Our data obtained from 3 
prospective randomized studies, show that regional anaesthetic techniques are associated with 
a 17% lower cortisol response than that of general anaesthesia over the first 24-h. Epidural 
anaesthesia techniques (especially when performed below the umbilicus) can lead to blunted 
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cortisol responses after surgery, in comparison to general anaesthesia. This effect seems more 
prominent when epidural anaesthetics are used instead of epidural opioids, probably because 
the first affect both sensory and sympathetic afferent stimuli, whereas opioids act on 
nociceptive pathways only.110  
 A limitation of this systematic review and meta-analysis is that serum cortisol has 
been measured with different assays. Immunoassays are known to have different degrees of 
cross-reactivity to endogenous and exogenous steroids other than cortisol,108,111,112 and this 
cross-reactivity can be exacerbated during stress, as the HPA axis activation leads to 
increased output of cortisol and its precursors.113 Moreover, inter-assay and inter-laboratory 
variability of serum cortisol measurements in patients with septic shock can be substantial for 
both immunoassays and LC-MS/MS-based techniques.114 If we refer to cortisol 
measurements through LC-MS/MS as the ‘gold standard’, our results confirm that 
immunoassays lead to an over-estimation of cortisol after surgery. However, data from LC-
MS/MS are very limited (only 2 studies from the same study group) and no cortisol 
measurements are available during or immediately after surgery, when the cortisol response 
is at its highest and the disagreement between LC-MS/MS and immunoassays is expected to 
be more apparent.115 
Another limitation is that we could only compile data on total cortisol. In healthy subjects, 
95% of serum cortisol is protein-bound, primarily to CBG and secondarily to albumin.116 
Five percent of serum cortisol is free (not protein-bound) and this is its bioactive form.117 
Several authors have observed a drop of CBG after surgery (up to 23-44% compared to 
baseline).57,71,99 This drop correlates with the severity of surgery,99 and can be interpreted as 
an adaptive mechanism to increase the delivery of bioactive cortisol to target tissues.118 The 
direct measurement of free cortisol is cumbersome and not routinely available in clinical 
settings, moreover, formulas to indirectly calculate unbound cortisol from total cortisol and 
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CBG values have been proven to be inaccurate after surgery, because of the effects of post-
operative hypoalbuminaemia and haemodilution.8,46,119 Notably, the drop of albumin can be 
substantial after CABG.71 The unavailability of free cortisol measurements in the included 
studies could have affected some of our observations. First, we did not observe a stratification 
of the total cortisol stress response between grade II and III surgical procedures – the high 
prevalence of CABG among grade III surgery (and thus the confounding effect of 
haemodilution, hypoalbuminaemia and CBG drop) may partially explain this. Moreover, 
studies including predominantly male patients mainly report total cortisol measurements from 
grade III procedures (CABG in most of the cases), and this may account for the differences 
that we observed among men and women. 
There is general agreement that the daily dose of glucocorticoids needs to be 
increased in patients with adrenal insufficiency undergoing surgery to prevent adrenal 
crisis, and that hydrocortisone is the treatment of choice.
5,120
 Nonetheless, no 
randomized controlled studies have assessed the precise glucocorticoid dose 
requirements in these patients and no consensus exists regarding the optimal 
management of perioperative glucocorticoid therapy. The perioperative glucocorticoid 
requirements detailed in the recent Endocrine Society guideline on diagnosis and 
treatment of primary adrenal insufficiency rely only on the severity of the surgical 
stress.
120
 The guideline recommends hydrocortisone 25-75mg/24h in adults for 1 to 2 
days after minor to moderate surgery and intravenous bolus of 100mg hydrocortisone 
followed by continuous infusion of 200mg/24h on the day of major surgery, to be 
tapered rapidly switching to oral regimen depending on clinical state.
120
 The results of 
this systematic review and meta-analysis suggest that other factors should be taken into 
account in addition to the magnitude of the surgical stress when deciding for the 
perioperative steroid coverage. According to the serum cortisol response, older subjects, 
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women and patients undergoing open surgery and general anaesthesia may require 
higher doses of hydrocortisone. Moreover, extra steroid coverage might be required at 
least up to one week following moderately to highly invasive procedures.  
 
CONCLUSIONS 
This systematic review and meta-analysis of the modern literature of cortisol response 
during surgery demonstrated significant differences of cortisol response in relation to the 
grade of surgery, with significantly higher cortisol response to grade II and III than to grade I 
surgery. We found that increased cortisol secretion continues up to the post-operative day 7 
after surgery and is affected by age, sex and invasiveness of the surgical or anaesthetic 
technique. Current evidence stems from highly heterogeneous studies of mostly moderate 
quality. Of note, only two of 71 included studies have used LC-MS/MS, which, however, is 
now considered state-of-the-art for the measurement of cortisol.121 Large prospective studies, 
entailing rigorous patient selection, stratification, and standardized outcome measurement by 
LC-MS/MS are needed to clarify how the adrenal gland responds to surgery and which 
factors shape this response. Such data would help to inform and tailor the current guidelines 
on glucocorticoid stress dose cover in hypoadrenal patients undergoing surgery. 
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FIGURE LEGENDS 
 
Figure 1 – PRISMA flow diagram. 
 
Figure 2 – Total serum cortisol concentrations according to the grade of surgery. All values 
are expressed in nmol/L and are reported as means ± 95% CI, obtained after meta-analysis of 
all included studies. The first value in each panel corresponds to baseline cortisol 
measurements before initiation of surgery. The cortisol measurement at time 0 corresponds to 
the initiation of surgery (Knife-To-Skin, KTS). Panel A) Comparison between the three 
grades of surgery over the fi st 24-h – the numbers 1 to 7 indicate the specific time points at 
which cortisol has been measured (1: baseline; 2: KTS; 3: during surgery; 4: end of surgery; 
5: first 6h after surgery; 6: between 6 and 18h after surgery; 7: 24-h after surgery). Panel B) 
Cortisol response over the first 24-h, after combining the data of surgery grade II and III 
(n=67 studies). Panel C) Surgery grade I (n=4 studies). Panel D) Surgery grade II (n=41 
studies). Panel E) Surgery grade III (n=22 studies). Panel F) Combined data of surgery 
grade II and III (n=67 studies). 
 
Figure 3 – Impact of age, sex and mean duration of surgery on total serum cortisol up to 48h 
after surgery. All values are expressed in nmol/L and are reported as means ± 95% CI, 
obtained after meta-analysis of all included studies. The first value in each panel corresponds 
to baseline cortisol measurements before initiation of surgery. The cortisol measurement at 
time 0 corresponds to the initiation of surgery. Panel A) Impact of patient age after 
combining data of surgery II and III – comparison between cohorts with a mean age of ≤60 
years (n=32 studies) or >60 years (n=21 studies). Panel B) Impact of gender after combining 
data of surgery II and III – comparison between cohorts including either >50% females (n=26 
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studies) or >50% males (n=25 studies). Panel C) Impact of the mean duration of surgery 
grade II – either ≤180 min (n=21 studies) or >180 min (n=4 studies). Panel D) Impact of the 
mean duration of surgery grade III – either ≤180 min (n=2 studies) or >180 min (n=10 
studies). 
 
Figure 4 – Total serum cortisol measurements according to differences in the surgical 
approach, anaesthetic techniques and four cortisol assays. All values are expressed in nmol/L 
and are reported as means ± 95% CI, obtained after meta-analysis of all included studies. The 
first value in each panel corresponds to baseline cortisol measurements before initiation of 
surgery. The cortisol measurement at time 0 corresponds to the initiation of surgery. Panel A) 
Studies comparing laparotomy (n=24 studies) and laparoscopic techniques (n=18 studies). 
Panel B) Studies either not using etomidate as an anaesthetic agent (n=38) or administering it 
to >50% of the patients (n=8). Panel C) Studies comparing general and regional anaesthesia 
(n=3). Panel D) Comparison of four cortisol assays (RIA, radioimmunoassay – n=33 studies; 
ECLIA, electrochemiluminescence immunoassay – n=17 studies; ELISA, enzyme-linked 
immunosorbent assays – n=6 studies; LC-MS/MS, liquid chromatography–tandem mass 
spectrometry – n=2 studies). 
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Table 1 – Included studies. 
Author (year) Country Study type Surgical procedure 
Grade of 
surgery 
a
 
Population 
Sample 
size 
Total cortisol 
assay 
Høgevold (1990) 
19
 Norway Prospective, observational Total hip replacement for osteoarthritis II 7 RIA 
Bartalena (1990) 20 Italy Prospective, observational Surgery for breast cancer, non-functioning 
adrenal cancer, adenocarcinoma of the 
colon, lung cancer, urethral obstruction 
II 10 RIA 
Hosokawa (1990) 
21
 Japan Prospective, observational Minor surgeries (e.g. tympanoplasty) and 
major surgeries (cholecystectomy) 
I, II 22 Double isotope 
dilution 
Bickel (1991) 
22
 Germany Prospective, randomized Elective cholecystectomy II 26 RIA 
Naito (1991) 23 Japan Prospective, observational Elective upper abdominal surgery II 15 RIA 
Juma (1991) 
24
 Saudi Arabia Prospective, observational Elective major orthopaedic surgery II 16 RIA 
Harris (1991) 
25
 USA Prospective, observational Surgery for traumatic thoracic and/or 
abdominal injuries 
III 10 RIA 
Donald (1993) 
26
 New Zealand Prospective, interventional Elective cholecystectomy II 12 ELISA 
McMahon (1993) 27 UK Prospective, randomized Elective cholecystectomy II 20 Fluorescent 
immunoassay 
Deuss (1994) 
28
 Germany Prospective, observational Elective cholecystectomy II 65 ELISA 
Crozier (1994) 
29
 Germany Prospective, randomized Elective hysterectomy for non-malignant 
diseases 
II 20 RIA 
Jakeways (1994) 
30
 UK Prospective, non-
randomized 
Elective cholecystectomy II 24 RIA 
Dionigi (1994) 31 Italy Prospective, randomized Elective cholecystectomy II 57 RIA 
Frank (1995) 
32
 USA Prospective, randomized Vascular, abdominal and thoracic surgery II, III 74 RIA 
Ellstrom (1996) 
33
 Sweden Prospective, randomized Hysterectomy for benign disorders II 24 Not reported 
Jameson (1997) 
34
 UK Prospective, randomized Hysterectomy II 16 RIA 
Karayiannakis (1997) 35 Greece Prospective, randomized Elective cholecystectomy II 83 RIA 
Roth-Isigkeit (1997) 
36
 Germany Prospective, observational Coronary artery bypass grafting surgery III 50 RIA 
Stratton (1997) 
37
 UK Prospective, observational Total hip replacement for osteoarthritis II 6 RIA 
Plunkett (1997) 
38
 USA Prospective, randomized Coronary artery bypass grafting surgery III 121 Fluorescent 
immunoassay 
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Eriksson-Mjöberg (1997) 39 Sweden Prospective, randomized Surgery for rectocele and cystocele II 30 RIA 
Bellón (1998) 40 Spain Prospective, observational Elective cholecystectomy II 28 RIA 
Engin (1998) 
41
 Turkey Prospective, randomized Elective cholecystectomy II 32 RIA 
Yamauchi (1998) 
42
 Japan Prospective, observational Laparoscopic cholecystectomy, modified 
radical-mastectomy, pulmonary lobectomy, 
thoracic oesophagectomy 
II, III 24 IRMA 
Delogu (1999) 43 Italy Prospective, observational Elective cholecystectomy II 46 RIA 
Friedrich (1998) 
44
 Germany Prospective, observational Surgery for either uterine leiomyomas, 
chronic pelvic discomfort or desire for 
definitive contraception 
II 20 RIA 
Vogeser (1999) 
45
 Germany Prospective, observational Cardiac surgery III 14 ECLIA 
Roth-Isigkeit (2000) 46 Germany Prospective, observational Coronary artery bypass grafting surgery III 28 RIA 
Schricker (2000) 
47
 Germany Prospective, randomized Hysterectomy II 20 RIA 
Cho (2000) 
48
 South Korea Prospective, observational Elective radical gastrectomy for gastric 
adenocarcinoma 
II 31 RIA 
Ogata (2000) 
49
 Japan Prospective, observational Elective partial gastrectomy II 16 RIA 
Mahla (2000) 50 Austria Prospective, observational Non-cardiac elective surgeries II 67 ELISA 
Nguyen (2002) 
51
 USA Prospective, randomized Gastric bypass II 48 RIA 
Ozarda Ilçöl (2002) 
52
 Turkey Prospective, observational Major abdominal or gynaecological surgery II 16 ECLIA 
Holub (2002) 
53
 Czech Republic Prospective, observational Hysterectomy for benign or premalignant 
pelvic disorders 
II 77 Fluorescent 
immunoassay 
Marana (2003) 54 Italy Prospective, randomized Ovarian cyst removal II 20 RIA 
Vogeser (2003) 
55
 Germany Prospective, observational Coronary artery bypass grafting surgery III 12 LC-MS/MS 
Vogeser (2003) 
56
 Germany Prospective, observational Coronary artery bypass grafting surgery III 16 LC-MS/MS 
le Roux (2003) 
57
 UK Prospective, observational Major elective surgery III 31 ELISA 
Lattermann (2003) 58 Canada Prospective, randomized Elective colorectal surgery II 16 RIA 
Shahbazi (2004) 
59
 Iran Prospective, interventional Coronary artery bypass grafting surgery III 30 RIA 
Maciejczyk-Pencula (2004) 
60
 Poland Prospective, randomized Hysterectomy for leiomyomas II 49 ELISA 
Haque (2004) 
61
 Bangladesh Prospective, interventional Elective cholecystectomy II 30 Not reported 
Ledowski (2005) 62 Germany Prospective, randomized Minor elective ear-nose-throat surgery I 43 ECLIA 
Crema (2005) 
63
 Brazil Prospective, interventional Elective cholecystectomy II 31 ECLIA 
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Yeager (2005) 64 USA Prospective, randomized Coronary artery bypass grafting surgery 
and/or cardiac valve replacement 
III 20 RIA 
Kudoh (2005) 
65
 Japan Prospective, observational Abdominal surgery II 115 Spectrophotome
try 
Nicholson (2005) 
66
 UK Prospective, observational Pelvic and/or acetabular reconstruction 
surgery for extensive fractures  
III 20 ELISA 
Rahr (2006) 
67
 Denmark Prospective, randomized Inguinal hernia repair I 61 ECLIA 
Buyukkocak (2006) 68 Turkey Prospective, randomized Anorectal surgery for benign conditions II 58 ECLIA 
Kashiwabara (2007) 
69
 Japan Prospective, observational Surgery of the digestive tract I, II, III 50 IRMA 
Baričević (2007) 
70
 Serbia Prospective, observational Surgery for malignant gastric or pancreatic 
tumours 
II 21 RIA 
Christ-Crain (2007) 
71
 UK Prospective, observational Coronary artery bypass grafting surgery III 24 ECLIA 
Rapp-Kesek (2007) 72 Sweden Prospective, randomized Coronary artery bypass grafting surgery III 18 Fluorescent 
immunoassay 
Spratt (2008) 
73
 USA Prospective, observational Abdominal aortic aneurysm resection and 
coronary artery bypass grafting surgery 
III 29 RIA 
Mujagić (2008) 
74
 Bosnia and 
Herzegovina, 
Croatia 
Prospective, randomized Low abdominal surgery (colon cancer, 
hysterectomy) 
II 50 Fluorescent 
immunoassay 
Bender (2009) 75 Turkey Prospective, randomized Inguinal hernia repair I 40 ECLIA 
Kim (2010) 
76
 South Korea Prospective, randomized Hysterectomy for non-malignant disease II 24 RIA 
Mu (2010) 
77
 China Prospective, observational Coronary artery bypass grafting surgery III 243 ECLIA 
Engin (2010) 
78
 Turkey Prospective, observational Elective abdominal surgery (for 
cholelithiasis, for gastroesophageal reflux or 
for gastric carcinoma) 
II 106 ECLIA 
Celic-Spuzic (2011) 
79
 Bosnia and 
Herzegovina 
Retrospective-prospective Prostatectomy for benign conditions III 100 RIA 
Mello (2011) 
80
 Brasil Prospective, observational Surgery requiring intensive care unit stay III 20 ECLIA 
Debono (2011) 
81
 UK Prospective, observational Coronary artery bypass grafting surgery III 30 ECLIA 
Adas (2013) 82 Turkey Prospective, observational Endoscopic retrograde 
cholangiopancreatography for bile duct 
stones 
I 50 Spectrophotome
try 
Mu (2013) 
83
 China Prospective, observational Coronary artery bypass grafting surgery III 166 ECLIA 
Ferreira (2014) 
84
 Brasil Prospective, interventional Cardiac surgery with cardiopulmonary 
bypass 
III 27 Not reported 
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Kahveci (2014) 85 Turkey Prospective, randomized Lower extremity surgery II 60 ECLIA 
Maas (2014) 
86
 The Netherlands Prospective, randomized Oesophagectomy for oesophageal 
carcinoma 
III 27 ECLIA 
Gu (2015) 
87
 China Prospective, randomized Oesophagectomy for oesophageal 
carcinoma 
III 57 RIA 
Lebherz (2016) 
88
 Germany Prospective, observational Cardiac surgery with cardiopulmonary 
bypass 
III 22 ECLIA 
Możański (2016) 89 Poland Prospective, randomized Elective abdominal laparoscopic surgery II 62 ECLIA 
a
 Refer to Supplementary Table 2 for the classification of the surgical procedures. When a subgroup analysis could not be performed within the study cohort(s), the grade of 
surgery was assigned according to the most frequent surgical procedure(s). 
 
Abbreviations: ECLIA: electrochemiluminescence; ELISA: enzyme-linked immunosorbent assay; IRMA: immunoradiometric assay; LC-MS/MS: liquid chromatography-
tandem mass spectrometry; RIA: radioimmunoassay.  
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Table 2 – Areas under the curve (AUCs) for total cortisol values, divided by 24-h periods and by the grade of surgery.  
 
AUC 0-24h 
AUC Day 1 
post-op. 
AUC Day 2 
post-op. 
AUC Day 3 
post-op. 
AUC Day 4 
post-op. 
AUC Day 5 
post-op. 
AUC Day 6 
post-op. 
AUC Day 7 
post-op. 
Surgery 
grade I 
Absolute value 
(nmol*h/L) 
9,541 n/a n/a n/a n/a n/a n/a n/a 
%difference to 
surgical baseline 
a
 
+11% n/a n/a n/a n/a n/a n/a n/a 
%difference to a 
standard 24-h AUC 
b
 
+116% n/a n/a n/a n/a n/a n/a n/a 
Surgery 
grade II 
Absolute value 
(nmol*h/L) 
18,066 13,152 13,032 13,272 13,320 12,972 10,980 10,392 
%difference to 
surgical baseline 
a
 
+102% +47% +46% +48% +49% +45% +23% +16% 
%difference to a 
standard 24-h AUC 
b
 
+309% n/a n/a n/a n/a n/a n/a n/a 
Surgery 
grade III 
Absolute value 
(nmol*h/L) 
16,010 14,904 12,636 11,820 n/a n/a 13,056 n/a 
%difference to 
surgical baseline 
a
 
+77% +65% +40% +31% n/a n/a +44% n/a 
%difference to a 
standard 24-h AUC 
b
 
+262% n/a n/a n/a n/a n/a n/a n/a 
Surgery 
grade 
II+III 
(combined) 
Absolute value 
(nmol*h/L) 
17,567 13,812 12,864 12,528 12,972 12,360 12,348 12,372 
%difference to 
surgical baseline 
a
 
+95% +53% +43% +39% +44% +37% +37% +37% 
%difference to a 
standard 24-h AUC 
b
 
+297% n/a n/a n/a n/a n/a n/a n/a 
During the first 24-h after surgery, multiple total cortisol measurements are available; therefore, the AUCs have been compared to a standard 24-h AUC for cortisol derived 
from the literature.
17,18
 From the first post-operative day onwards only measurements every 24-h are available, therefore the AUCs have been compared to AUCs calculated 
according to the baseline cortisol values. 
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a
 Percentage difference between the AUC and the pre-surgical AUC. The pre-operative AUC has been calculated by considering a 24-h period between two identical total 
cortisol values, derived from the baseline cortisol measurements (prior to the initiation of surgery). The calculated pre-operative AUCs for surgery grade I, II, III and II+III are 
8,616 nmol*h/L, 8,952 nmol*h/L, 9,048 nmol*h/L, 9,000 nmol*h/L, respectively. 
 
b
 Percentage difference between the AUC and a standard 24-h AUC for cortisol obtained by 24-h cortisol profiling of 33 healthy adults (4,420 nmol*h/L).
17,18
 
 
Abbreviations: AUC: area under the curve for serum cortisol values; n/a: not available or not applicable. 
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Records screened
(n = 7598)
Full-text articles 
assessed for eligibility
(n = 438)
Studies included in 
quantitative synthesis 
(meta-analysis)
(n = 71)
Records excluded 
(n = 7160)
N = 381 studies excluded after full-
text screening, with reasons:
• N=249 no population of interest
• N=48 no cortisol measurements
• N=38 non-English language
• N=32 review articles
• N=14 other
Records after 
duplicates removed
(n = 7598)
Id
e
n
ti
fi
c
a
ti
o
n
S
c
re
e
n
in
g
Records identified through 
database searching
(n = 7619)
E
li
g
ib
il
it
y
In
c
lu
d
e
d
Additional records 
identified through 
other sources
(n = 15)
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C – Surgery grade I D – Surgery grade II
E – Surgery grade III F – Surgery II + III (combined)
A – First 24h B – First 24 (surgery II + III)
1
2
3
44
5
6
6
7
5
5
3
43
7
1
2
3
4 5 6
Page 41 of 56 Clinical Endocrinology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Page 42 of 56Clinical Endocrinology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
C – General vs. regional anaesthesia D – Total serum cortisol assays
A – Laparotomy vs. laparoscopy B – Use of etomidate
/MS
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Supplementary Table 1 – Full search strategy. 
Ovid 
Database(s): Embase 1988 to 2016 Week 21, Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to Present, EBM Reviews - 
Cochrane Central Register of Controlled Trials April 2016, EBM Reviews - Cochrane Database of Systematic Reviews 2005 to May 25, 2016  
Search Strategy: 
# Searches Results Annotations 
1 exp Hydrocortisone/ 149584 
 
2 exp Cortisone/ 29070 
 
3 cortisone acetate/ 1061 
 
4 Glucocorticoids/ 106016 
 
5 Dehydroepiandrosterone Sulfate/ 11203 
 
6 
(adreson or corticosteroid* or cortifair or cortisol or cortisone or cortril or dehydrocortisone or "Dehydroepiandrosterone Sulfate" or DHEAS or 
epicortisol or Glucocorticoid* or hydrocortisone).mp. 
658684 
 
7 1 or 2 or 3 or 4 or 5 or 6 661993 
 
8 blood.fs. 1554351 
 
9 metabolism.fs. 4636381 
 
10 
("adrenal function*" or "adrenal reserve" or "adrenal response" or analys* or analyz* or assay* or assess* or blood or concentration* or measur* 
or pharmacokinetic* or saliva or serum or urine).mp. 
23423278 
 
11 8 or 9 or 10 25720523 
 
12 
exp *Hydrocortisone/ or exp *Cortisone/ or *cortisone acetate/ or *Glucocorticoids/ or *Dehydroepiandrosterone Sulfate/ or (adreson or 
corticosteroid* or cortifair or cortisol or cortisone or cortril or dehydrocortisone or "Dehydroepiandrosterone Sulfate" or DHEAS or epicortisol or 
Glucocorticoid* or hydrocortisone).ti. 
184113 
 
13 
12 and ("adrenal function*" or "adrenal reserve" or "adrenal response" or analys* or analyz* or assay* or assess* or blood or concentration* or 
measur* or pharmacokinetic* or saliva or serum or urine).ti. 
18392 
 
14 
((critical* adj3 ill*) or burn or burns or "multi-organ dysfunction*" or "multi-organ failure" or "multiple organ dysfunction*" or "multiple organ 
failure" or polytrauma* or trauma*).mp. 
919041 
 
15 7 and 11 and 14 12792 
 
16 13 or 15 30747 
 
17 16 not "traumatic brain injur*".ti. 30284 
 
18 17 not "conference abstract".pt. 28307 
 
19 limit 18 to yr="1980 -Current" 25076 
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20 (exp animals/ or exp nonhuman/) not exp humans/ 8423008 
 
21 
((alpaca or alpacas or amphibian or amphibians or animal or animals or antelope or armadillo or armadillos or avian or baboon or baboons or 
beagle or beagles or bee or bees or bird or birds or bison or bovine or buffalo or buffaloes or buffalos or "c elegans" or "Caenorhabditis elegans" 
or camel or camels or canine or canines or carp or cats or cattle or chick or chicken or chickens or chicks or chimp or chimpanze or chimpanzees 
or chimps or cow or cows or "D melanogaster" or "dairy calf" or "dairy calves" or deer or dog or dogs or donkey or donkeys or drosophila or 
"Drosophila melanogaster" or duck or duckling or ducklings or ducks or equid or equids or equine or equines or feline or felines or ferret or 
ferrets or finch or finches or fish or flatworm or flatworms or fox or foxes or frog or frogs or "fruit flies" or "fruit fly" or "G mellonella" or 
"Galleria mellonella" or geese or gerbil or gerbils or goat or goats or goose or gorilla or gorillas or hamster or hamsters or hare or hares or heifer 
or heifers or horse or horses or insect or insects or jellyfish or kangaroo or kangaroos or kitten or kittens or lagomorph or lagomorphs or lamb or 
lambs or llama or llamas or macaque or macaques or macaw or macaws or marmoset or marmosets or mice or minipig or minipigs or mink or 
minks or monkey or monkeys or mouse or mule or mules or nematode or nematodes or octopus or octopuses or orangutan or "orang-utan" or 
orangutans or "orang-utans" or oxen or parrot or parrots or pig or pigeon or pigeons or piglet or piglets or pigs or porcine or primate or primates or 
quail or rabbit or rabbits or rat or rats or reptile or reptiles or rodent or rodents or ruminant or ruminants or salmon or sheep or shrimp or slug or 
slugs or swine or tamarin or tamarins or toad or toads or trout or urchin or urchins or vole or voles or waxworm or waxworms or worm or worms 
or xenopus or "zebra fish" or zebrafish) not (human or humans)).mp. 
7384547 
 
22 19 not (20 or 21) 20693 
 
23 
limit 22 to ("all adult (19 plus years)" or "young adult (19 to 24 years)" or "adult (19 to 44 years)" or "young adult and adult (19-24 and 19-44)" or 
"middle age (45 to 64 years)" or "middle aged (45 plus years)" or "all aged (65 and over)" or "aged (80 and over)") [Limit not valid in 
Embase,CCTR,CDSR; records were retained] 
16937 
 
24 
limit 23 to (adult <18 to 64 years> or aged <65+ years>) [Limit not valid in Ovid MEDLINE(R),Ovid MEDLINE(R) In-Process,CCTR,CDSR; 
records were retained] 
11411 
 
25 
limit 22 to ("all infant (birth to 23 months)" or "all child (0 to 18 years)" or "newborn infant (birth to 1 month)" or "infant (1 to 23 months)" or 
"preschool child (2 to 5 years)" or "child (6 to 12 years)" or "adolescent (13 to 18 years)") [Limit not valid in Embase,CCTR,CDSR; records were 
retained] 
14125 
 
26 
limit 25 to (embryo or infant or child or preschool child <1 to 6 years> or school child <7 to 12 years> or adolescent <13 to 17 years>) [Limit not 
valid in Ovid MEDLINE(R),Ovid MEDLINE(R) In-Process,CCTR,CDSR; records were retained] 
3963 
 
27 26 not 24 1469 
 
28 22 not 27 19224 
 
29 
limit 28 to (editorial or erratum or letter or note or addresses or autobiography or bibliography or biography or blogs or comment or dictionary or 
directory or interactive tutorial or interview or lectures or legal cases or legislation or news or newspaper article or overall or patient education 
handout or periodical index or portraits or published erratum or video-audio media or webcasts) [Limit not valid in Embase,Ovid 
MEDLINE(R),Ovid MEDLINE(R) In-Process,CCTR,CDSR; records were retained] 
1178 
 
30 from 29 keep 1-1066 1066 
 
31 28 not 30 18158 
 
32 limit 31 to yr="2012 -Current" 4498 
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33 remove duplicates from 32 3067 
 
34 limit 31 to yr="2007 -2011" 4237 
 
35 remove duplicates from 34 2957 
 
36 limit 31 to yr="2001 -2006" 3749 
 
37 remove duplicates from 36 2499 
 
38 limit 31 to yr="1993 -2000" 3075 
 
39 remove duplicates from 38 1945 
 
40 31 not (32 or 34 or 36 or 38) 2599 
 
41 remove duplicates from 40 1945 
 
42 33 or 35 or 37 or 39 or 41 12413 
 
43 (case adj3 report*).mp,pt. 3575111 
 
44 (systematic adj3 review).mp,pt. 235991 
 
45 review.mp,pt. 5358492 
 
46 45 not 44 5122501 
 
47 42 not 46 9903 
 
48 47 not 43 9131 
 
49 limit 48 to yr="1990 -Current" 7919 
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Supplementary Table 2 – Classification of surgical procedures (adapted from the modified Johns Hopkins surgical criteria).
12
 
Grade General description Includes Excludes 
I Minimal to mild risk independent to anaesthesia. 
Minimal to moderately invasive procedure. 
Potential blood loss less than 500 ml. 
Breast biopsy; removal of minor skin or subcutaneous 
lesions; myringotomy tubes; hysteroscopy; cystoscopy; 
vasectomy; circumcision; fibre-optic bronchoscopy; 
diagnostic laparoscopy; dilatation and curettage; 
fallopian tube ligation; arthroscopy; inguinal hernia 
repair; laparoscopic lysis of adhesion; tonsillectomy; 
rhinoplasty. 
Open exposure of internal body organs; 
repair of vascular or neurological 
structures; placement of prosthetic 
devices; post-operative monitored care 
setting; open exposure of abdomen, 
thorax, neck, cranium; resection of major 
body organs. 
II Moderately to significantly invasive procedures. 
Potential blood loss 500–1500 ml. 
Moderate risk to patient independent of anaesthesia. 
Thyroidectomy; hysterectomy; myomectomy; 
cystectomy; cholecystectomy; laminectomy; hip/knee 
replacement; nephrectomy; major laparoscopic 
procedures; resection/reconstructive surgery of the 
digestive tract. 
Open thoracic or intracranial procedure; 
major vascular repair (e.g. aorto-femoral 
bypass); planned post-operative 
monitored care setting (intensive care 
unit, post anaesthesia care unit). 
III Highly invasive procedures. 
Potential blood loss greater than 1500 ml. 
Major to critical risk to patient independent of anaesthesia. 
Usual post-operative intensive care unit stay with invasive 
monitoring. 
Major orthopaedic-spinal reconstruction; major 
reconstruction of the gastrointestinal tract; major 
genitourinary surgery (e.g. radical retro-pubic 
prostatectomy); cardiothoracic procedures; intracranial 
procedures; major procedures on the oropharynx; major 
vascular, skeletal, neurological repair. 
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Supplementary Table 3 – Subgroup analyses performed for meta-analysis.  
Parameters 
Day of 
surgery 
a
 
Day 1 
post-op. 
Day 2 
post-op. 
Day 3 
post-op. 
Day 4 
post-op. 
Day 5 
post-op. 
Day 6 
post-op. 
Day 7 
post-op. 
References 
Grade of surgery 
b
 Grade I SS: 659 SS: 90 n/a n/a n/a n/a n/a n/a 
21, 62, 67, 69, 75, 82
 
Grade II SS: 3,829 SS: 981 SS: 366 SS: 121 SS: 75 SS: 16 SS: 10 SS: 71 
19-24, 26-35, 37, 39-44, 47-
54, 58, 60, 61, 63, 65, 66, 
68-70, 74, 76, 78, 85, 89 
Grade III SS: 1,749 SS: 871 SS: 209 SS: 67 SS: 55 n/a SS: 18 SS: 27 
25, 32, 36, 38, 42, 45, 46, 
55-57, 64, 69, 71-73, 77, 79-
81, 83, 84, 86-88
 
Age 
c
 
Grade II, ≤60 years SS: 2,987 SS: 601 SS: 150 SS: 69 n/a n/a n/a n/a 
22, 28, 30, 31, 34, 35, 40, 
42-44, 47, 48, 51, 53, 54, 58, 
61, 63, 65, 66, 68, 76, 78, 
85, 89
 
Grade II, >60 years SS: 533 SS: 158 SS: 98 SS: 6 SS: 6 n/a n/a n/a 
28, 37, 39, 50, 58, 65, 69, 
78, 85
 
Grade III, ≤60 years SS: 597 SS: 320 SS: 135 n/a n/a n/a n/a n/a 
36, 46, 57, 73, 83, 84, 87
 
Grade III, >60 years SS: 809 SS: 472 SS: 22 SS: 12 n/a n/a SS: 18 n/a 
38, 42, 59, 64, 69, 71-73, 77, 
80, 81, 88
 
Gender 
d
 
Grade II+III, >50% 
females 
SS: 2,205 SS: 588 SS: 119 SS: 77 SS: 49 n/a n/a SS: 49 
19, 23, 25, 27-32, 36, 37, 40, 
41, 44, 48, 50, 51, 54, 57, 
58, 60, 67, 71, 73, 77
 
Grade II+III, >50% 
males 
SS: 2,143 
SS: 
1,088 
SS: 345 SS: 39 SS: 55 n/a n/a SS: 43 
42, 45, 47, 52, 53, 56, 62, 
65, 66, 68, 74, 76, 80, 82, 
83, 85
 
Duration of surgery 
e
 
Grade II, ≤180 min SS: 2,278 SS: 558 SS: 115 SS: 89 n/a n/a n/a n/a 
19, 23, 24, 27, 28, 31, 32, 
38-41, 44, 50, 51, 55, 62, 65, 
73, 82, 86 
Grade II, >180 min SS: 221 SS: 31 SS: 31 n/a n/a n/a n/a n/a 
45, 48, 66 
Grade III, ≤180 min SS: 279 SS: 57 SS: 57 n/a n/a n/a n/a n/a 
84, 87
 
Grade III, >180 min SS: 865 SS: 668 SS: 100 SS: 12 n/a n/a n/a n/a 
36, 38, 42, 46, 69, 71, 77, 
81, 83, 88
 
Surgical technique 
f
 
Laparoscopy SS: 1,086 SS: 270 n/a SS: 64 n/a n/a n/a n/a 
26-28, 30, 31, 33, 35, 40-44, 
51, 53, 61, 63, 76, 89
 
Laparotomy SS: 1,676 SS: 411 SS: 221 SS: 34 SS: 49 n/a n/a n/a 
23-25, 27, 28, 30, 32, 37, 38, 
40, 41, 45, 46, 48-50, 57, 58, 
60, 62, 66, 73, 75 
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Anaesthesia 
g
 Grade II+III, etomidate 
used in >50% of 
patients 
SS: 320 SS: 523 SS: 104 SS: 12 SS: 12 n/a n/a n/a 
34, 36, 45, 46, 55, 77, 83, 89
 
Grade II+III, no 
etomidate used 
SS: 3,761 SS: 884 SS: 268 SS: 40 SS: 10 SS: 16 SS: 10 SS: 6 
16, 17, 19, 20, 23, 25, 27-32, 
34-40, 44, 51, 54-56, 61-63, 
65, 66, 68, 71, 76-78, 82, 84, 
86 
General anaesthesia SS: 142 SS: 59 n/a n/a n/a n/a n/a n/a 58, 68, 85
 
Regional anaesthesia SS: 142 SS: 59 n/a n/a n/a n/a n/a n/a 
Assay 
h
 
RIA SS: 2,715 SS: 548 SS: 223 SS: 16 SS: 26 SS: 16 SS: 10 SS: 22 
19, 20, 22-25, 29-32, 34-37, 
39-41, 43, 44, 46-49, 51, 54, 
58, 59, 64, 70, 73, 76, 79, 87
 
ECLIA SS: 1,117 SS: 683 SS: 67 SS: 43 SS: 27 n/a n/a SS: 27 
45, 52, 63, 68, 71, 77, 78, 
80, 81, 83, 85, 86, 88, 89 
ELISA SS: 547 SS: 229 SS: 114 n/a SS: 49 n/a n/a SS: 49 26, 28, 50, 57, 60, 66 
LC-MS/MS SS: 28 SS: 28 SS: 28 SS: 28 SS: 28 n/a n/a n/a 55, 56 
ALL STUDIES 
n=2,953 patients 
SS: 6,460 
SS: 
2,149 
SS: 590 SS: 257 SS: 130 SS: 16 SS: 28 SS: 141 Listed in Table 1 
The studies included in each subgroup analysis are reported in the last column. For each parameter assessed the cumulative sample size (SS – number of single cortisol 
measurements) is reported. These are divided by time points, which cover from the baseline assessment (prior to surgery) up to the 7
th
 post-operative day. The cortisol 
responses for each subgroup analysis are reported in Figures 2 to 4. 
 
a 
Serum cortisol measurements during the day of surgery have been captured according to six time points: time 1, baseline (before surgery); time 2, initiation of surgery; time 
3, during surgery; time 4, end of surgery; time 5, first 6h after surgery; time 6, between 6 and 18h after surgery. The SSs reported in this column correspond to the sum of all 
the six time points. 
b The grade of surgery has been defined according the classification reported in Supplementary Table 2. 
c
 The cohorts have been divided according to the grade of surgery and to the mean age of patients being ≤ or >60 years. 
d
 The cohorts have been divided according to the percentage of males and females. Only cohorts with either >50% females or >50% males have been included. 
e
 The cohorts have been divided according to the grade and the mean duration of surgery (either ≤180 or >180 minutes). 
f Only the cohorts of patients who underwent either laparotomies or abdominal/pelvic laparoscopies have been included for analysis.  
g
 We included only cohorts for which the anaesthetic technique was described in detail. As for the use of etomidate, we compared cohorts in which etomidate was not used as 
an anaesthetic agent to cohorts where this was used in >50% of patients. As far as the anaesthetic technique is concerned, we used data derived from prospective 
interventional studied comparing general and regional anaesthesia (either spinal or epidural thoracolumbar anaesthesia). 
h We have divided studies according to the cortisol assays used. 
 
Abbreviations: ECLIA: electrochemiluminescence; ELISA: enzyme-linked immunosorbent assay; IRMA: immunoradiometric assay; LC-MS/MS: liquid chromatography-
tandem mass spectrometry; n=number of studies; SS: sample size; RIA: radioimmunoassay; n/a: not available. 
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Supplementary Table 4 – Methodological quality assessment of the included studies. 
First author (year of 
publication) 
Patients (inclusion 
criteria) a 
Patients (exclusion 
criteria) b 
Cortisol 
measurement 
(methodology) c 
Cortisol 
measurement 
(timing) d 
Cortisol 
measurement 
(reporting) e 
Cortisol 
measurement 
(time points) f 
Høgevold (1990) 19 Yes Unclear Yes Yes Yes Yes 
Bartalena (1990) 20 Yes Unclear Yes Yes Yes Yes 
Hosokawa (1990) 21 Yes Unclear Yes Yes Yes Yes 
Bickel (1991) 22 Somewhat Yes Yes Yes Yes Yes 
Naito (1991) 23 Somewhat Somewhat Yes Somewhat Somewhat Yes 
Juma (1991) 24 Yes Unclear Yes Yes Yes Yes 
Harris (1991) 25 Somewhat Unclear Yes Yes Yes Yes 
Donald (1993) 26 No Unclear Yes Yes Yes Yes 
McMahon (1993) 27 Somewhat Unclear Yes Yes Yes Somewhat 
Deuss (1994) 28 Somewhat Unclear Yes Yes Yes Yes 
Crozier (1994) 29 Yes Unclear Yes Yes Yes Yes 
Jakeways (1994) 30 Yes Unclear Somewhat Yes Yes Yes 
Dionigi (1994) 31 Yes Unclear Somewhat Yes Yes Somewhat 
Frank (1995) 32 Unclear Unclear Yes Somewhat Yes Yes 
Ellstrom (1996) 33 Yes Unclear No Yes Yes Yes 
Jameson (1997) 34 Somewhat Unclear Yes Yes Yes Yes 
Karayiannakis (1997) 35 Yes Yes Yes Yes Yes Yes 
Roth-Isigkeit (1997) 36 Yes Yes Yes Yes Yes Yes 
Stratton (1997) 37 Yes Unclear Yes Yes Yes Yes 
Plunkett (1997) 38 Yes Unclear Yes Yes Yes Yes 
Eriksson-Mjöberg (1997) 39 Yes Yes Yes Yes Yes Somewhat 
Bellón (1998) 40 Somewhat Unclear Yes Yes Yes Yes 
Engin (1998) 41 Yes Yes Yes Somewhat Yes Yes 
Yamauchi (1998) 42 Yes Yes Yes Yes Yes Yes 
Delogu (1999) 43 Yes Yes Yes Somewhat Yes Yes 
Friedrich (1998) 44 Yes Yes Somewhat Yes Yes Yes 
Vogeser (1999) 45 Yes Yes Yes Yes Yes Yes 
Roth-Isigkeit (2000) 46 Yes Somewhat Yes Yes Yes Yes 
Schricker (2000) 47 Yes Yes Yes Yes Yes Yes 
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Cho (2000) 48 Yes Yes Yes Somewhat Yes Yes 
Ogata (2000) 49 Yes Unclear Yes Yes Yes Yes 
Mahla (2000) 50 Yes Unclear Yes Yes Yes Yes 
Nguyen (2002) 51 Yes Unclear Yes Yes Yes Yes 
Ozarda Ilçöl (2002) 52 Yes Unclear Yes Yes Yes Yes 
Holub (2002) 53 Yes Unclear Yes Yes Yes Yes 
Marana (2003) 54 Yes Yes Yes Yes Yes Yes 
Vogeser (2003) 55 Yes Unclear Yes Yes Yes Yes 
Vogeser (2003) 56 Yes Unclear Yes Somewhat Yes Yes 
le Roux (2003) 57 Yes Yes Yes Yes Yes Yes 
Lattermann (2003) 58 Yes Yes Yes Somewhat Yes Yes 
Shahbazi (2004) 59 No Unclear Yes Yes Yes Yes 
Maciejczyk-Pencula (2004) 60 Yes Unclear Yes Yes Yes Yes 
Haque (2004) 61 Yes Unclear No Yes Yes Yes 
Ledowski (2005) 62 Yes Yes Yes Yes Yes Yes 
Crema (2005) 63 Yes Unclear Yes Yes Yes Yes 
Yeager (2005) 64 Yes Yes Yes Yes Yes Yes 
Kudoh (2005) 65 Yes Unclear Somewhat Yes Yes Yes 
Nicholson (2005) 66 Yes Yes Yes Yes Yes Yes 
Rahr (2006) 67 Somewhat Unclear Yes Yes Yes Yes 
Buyukkocak (2006) 68 Yes Yes Yes Yes Yes Yes 
Kashiwabara (2007) 69 Yes Yes Yes Yes Yes Yes 
Baričević (2007) 70 Yes Unclear Yes Yes Yes Yes 
Christ-Crain (2007) 71 Yes Yes Yes Yes Yes Yes 
Rapp-Kesek (2007) 72 Yes Unclear Yes Yes Yes Yes 
Spratt (2008) 73 Yes Yes Yes Yes Yes Yes 
Mujagić (2008) 74 Yes Yes Yes Yes Yes Yes 
Bender (2009) 75 Yes Unclear Yes Yes Yes Yes 
Kim (2010) 76 Yes Yes Yes Yes Yes Yes 
Mu (2010) 77 Yes Yes Yes Yes Yes No 
Engin (2010) 78 Yes Yes Yes Somewhat Yes Somewhat 
Celic-Spuzic (2011) 79 Yes Unclear Yes Yes Yes Somewhat 
Mello (2011) 80 Yes Yes Yes Yes Yes Yes 
Debono (2011) 81 Yes Yes Yes Yes Yes Yes 
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Adas (2013) 82 Yes Unclear Somewhat Yes Yes Yes 
Mu (2013) 83 Yes Yes Yes Yes Yes Yes 
Ferreira (2014) 84 Yes Unclear No Yes Yes Yes 
Kahveci (2014) 85 Yes Unclear Yes Yes Yes Yes 
Maas (2014) 86 Somewhat Unclear Yes Yes Yes Yes 
Gu (2015) 87 Yes Unclear Yes Yes Yes Yes 
Lebherz (2016) 88 Yes Yes Yes Yes Yes Yes 
Możański (2016) 89 Yes Yes Yes Yes Yes Yes 
a Question answered to assess the quality of the study – Are inclusion criteria for cohort selection described in sufficient detail? 
b Question answered to assess the quality of the study – Are patients on steroids or any other disease influencing endogenous steroid production excluded? 
c Question answered to assess the quality of the study – Is the cortisol assay used clearly reported? 
d Question answered to assess the quality of the study – Is the timing of cortisol measurement clearly reported? 
e Question answered to assess the quality of the study – Is the cortisol measurement reported for the whole cohort? 
f Question answered to assess the quality of the study – Is it possible to correlate the cortisol measurement to a specific time point for the cohort reported? 
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Supplementary Table 6 – Factors potentially affecting the perioperative cortisol response and the measurement of total serum cortisol. 
Factors Assessed in this article Other factors 
Patient 
characteristics 
• Patient age; 
• Patient gender. 
• Comorbidities: these are not always clearly reported in the inclusion/exclusion criteria of the articles included. 
Some disorders can alter the cortisol metabolism (e.g. liver disease, nephrotic syndrome, thyrotoxicosis, 
hypothyroidism and diabetes mellitus). The exclusion of patients with adrenal or pituitary disorders is not always 
specified in the articles included in this systematic review; 
• ASA physical status: not all the studies included in this article specify the ASA physical status. When it is 
specified, it can vary considerably among the included cohorts. The ASA physical status correlates with the 
duration of hospital stay and post-operative complications, that can affect the cortisol response; 
• Nutrition status: malnutrition can enhance the cortisol output; 
• Studies including patients undergoing surgery for traumatic lesions do not always specify if some of the patients 
experienced head trauma. Head trauma can lead to temporary or long-term central adrenal insufficiency;  
• Several medications can potentially affect the cortisol metabolism and measurement, and their use is not always 
specified in the included articles (medications specifically used for the treatment of endogenous hypercortisolism 
and adrenocortical cancer are not reported):  
o Increase of CBG – e.g. Oestrogens; Tamoxifen. 
o Medications enhancing the CYP3A4 activity – e.g. Barbiturates; Carbamazepine; Oxcarbazepine; Phenytoin; 
Reverse transcriptase inhibitors; Rifampicin;  
o Medications inhibiting the CYP3A4 activity – e.g. Amiodarone; Azole antifungals; Chloramphenicol; 
Clarithromycin; Nefazodone; Nicardipine; Protease inhibitors; 
o Medications binding to the glucocorticoid receptor: Medroxyprogesterone acetate; Megestrol acetate; 
o Medications having an action on pituitary ACTH production: Glitazones; 
o Cross-reactivity with cortisol assays: Biotin; Quinine; Quinidine; Spironolactone. 
Features of 
surgery 
• Grade of surgery (as per the 
modified Johns Hopkins 
surgical criteria); 
• Laparotomy vs. laparoscopy; 
• Surgery for malignant conditions: radical resection for cancer is often associated with greater surgical trauma and 
longer operative time; 
• Surgery for post-traumatic lesions: surgery after trauma can be associated with longer operative time, greater 
blood loss and higher risk of complications; 
• Non-elective surgery: it is associated with higher rates of complications; 
• Perioperative haemodilution and/or hypoproteinaemia (due to blood loss or intravenous fluid administration): it 
can causes to falsely lower cortisol values; 
• Post-operative drop of CBG. 
Anaesthetic 
techniques 
• General vs. regional 
anaesthesia; 
• Use of etomidate. 
• Epidural anaesthesia techniques (especially when performed below the umbilicus) can lead to blunted cortisol 
responses after surgery, in comparison to general anaesthesia. When epidural anaesthesia is used for thoracic and 
upper abdominal surgeries, the modulatory effect on cortisol secretion is less evident.
114
 However, a recent study 
suggests that the combination of general anaesthesia and thoracic epidural blockade is more efficient in 
determining a reduction of the cortisol response in comparison to general anaesthesia alone;
87
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• Opiates are known to suppress cortisol secretion. General anaesthesia with opiates (especially when high doses 
are used) can blunt the cortisol response,47,115-117 but not all authors confirmed these observations.43,92,118 In 
cardiac surgery, the cortisol response induced by the cardiopulmonary bypass appears to overcome the inhibitory 
effects of high-dose opiates;
114
 
• Sevoflurane anesthesia in patients undergoing laparoscopic pelvic surgery was associated with significantly lower 
concentrations of ACTH and cortisol (during and immediately after surgery), when compared to Isoflurane;
54
 
• Patients receiving a balanced anaesthesia (Sevoflurane/Remifentanil) showed higher cortisol levels after 
extubation, when compared to a total intravenous anaesthesia (Propofol/Remifentanil).62  
• Midazolam: it is a benzodiazepine containing an imidazole ring (like Etomidate). It can attenuate the cortisol 
response after surgery;2,119 
• Perioperative use of steroids: not always specified as an exclusion criterion in the articles included in this 
systematic review and meta-analysis. 
Post-operative 
complications 
 Post-operative complications (e.g. fever, haemorrhage, infections and sepsis, acute confusion) are a cause of stress 
and can affect the cortisol output. Not all studies included in this article specify post-operative complications. One 
study reported data from patients with post-operative sepsis.
70
 
Post-operative 
care 
 Several factors can potentially affect the stress cortisol response after surgery, for example: 
• Admission to the intensive care unit; 
• Intraoperative normothermia: the fall of core body temperature can stimulate the stress response to surgery 
(cortisol and catecholamines), while post-operative forced air warming can blunt the cortisol surge;
32
 
• Post-operative sedation: it helps reducing the surgical stress index post-operatively.
120
 The use of sedatives and 
hypnotics can interfere with the sleeping patterns and the circadian rhythm;  
• Post-operative management of pain, nausea and vomiting; 
• Management of drains, tubes and catheters; 
• Timing of post-operative nutrition and mob lization. 
Methodological 
factors 
Total cortisol assays Several factors may have an impact on the total cortisol values that have been extracted for this systematic review and 
meta-analysis: 
• The timing of cortisol measurements is not always clearly reported; 
• Most of pre- and post-operative cortisol measurements have been performed during the morning. However, this is 
not always specified; 
• Some of the included articles did not report the exact cortisol values, which have been therefore extracted from 
graphs. 
Abbreviations: ACTH: adrenocorticotropic hormone; ASA: American Society of Anesthesiologists; CBG: cortisol-binding globulin; CYP3A4: Cytochrome P450 3A4. 
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